Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Vanda Pharmaceuticals Inc.

Law Offices of Howard G. Smith reminds investors of the upcoming April
26, 2019 deadline to file a lead plaintiff motion in the class
action filed on behalf of investors who purchased Vanda Pharmaceuticals
Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA)
securities between November 4, 2015 and February 11, 2019,
inclusive (the “Class Period”).

Investors suffering losses on their Vanda investments are encouraged to
contact the Law Offices of Howard G. Smith to discuss their legal rights
in this class action at 888-638-4847 or by email to [email protected].

On February 11, 2019, Aurelius Value published an article reporting that
a Qui Tam lawsuit filed by a whistleblower was recently unsealed,
containing allegations of “illegal off-label promotion of both of
Vanda’s drugs, Vanda’s participation in a fraud involving doctors
writing hundreds of ‘fake prescriptions’ and pocketing cash using
Vanda-issued copay cards, falsified documents in internal systems, and
resignations of senior executives who refused to participate in illegal
activity.” On this news, Vanda’s share price fell, thereby injuring
investors.

The Complaint filed in this class action alleges that Defendants made
materially false and misleading statements and/or failed to disclose
that: (1) Vanda was engaged in a fraudulent scheme in which it promoted
the off-label use of Fanapt and Hetlioz; (2) the company was
fraudulently receiving drug reimbursements from the government by
abusing Medicare, Medicaid, and Tricare programs; (3) as a result of the
scheme, Vanda faced legal action from the government; (4) Vanda's
promotional materials for Fanapt and Hetlioz were false and misleading,
garnering regulatory scrutiny from the U.S. Food and Drug
Administration; and (5) as a result, defendants' statements about
Vanda's business, operations and prospects were materially false and
misleading and/or lacked a reasonable basis at all relevant times.

If you purchased shares of Vanda during the Class Period you may move
the Court no later than April 26, 2019 to ask the Court
to appoint you as lead plaintiff if you meet certain legal requirements.
To be a member of the class action you need not take any action at this
time; you may retain counsel of your choice or take no action and remain
an absent member of the class action. If you wish to learn more about
this class action, or if you have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Howard G. Smith, Esquire, of Law Offices of Howard G.
Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by
telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected],
or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190329005465/en/